"सदस्य:Prong$31/प्रयोगपृष्ठ": अवतरणों में अंतर
Content deleted Content added
छो 1997kB ने सदस्य:Godric ki Kothri/प्रयोगपृष्ठ पृष्ठ सदस्य:Prong$31/प्रयोगपृष्ठ पर स्थानांतरित किया: "Godric ki Kothri" का नाम "Prong$31" करते समय पृष्ठ स्वतः स्थानांतरित हुआ। |
No edit summary |
||
पंक्ति 5:
* <code><nowiki><ref>{{cite news|url= |title= |publisher= |date= |accessdate=}}</ref></nowiki></code>
* <code><nowiki><ref>{{HPref|book=|chapter=}}</ref></nowiki></code>
{{Infobox drug
| Verifiedfields =
| verifiedrevid =
| drug_name =
| INN = tozinameran
| type = vaccine
| image = Covid19 vaccine biontech pfizer 3.jpg
| alt =
| width =
| caption = A vial of the Pfizer–BioNTech COVID‑19 vaccine for the U.S. market
<!-- Vaccine data -->
| target = [[Severe acute respiratory syndrome coronavirus 2|SARS-CoV-2]]
| vaccine_type = mrna
<!-- Clinical data -->
| pronounce = ''Tozinameran'': {{IPAc-en|ˌ|t|oʊ|z|ɪ|ˈ|n|æ|m|ər|ən}} {{respell|TOH|zih|NAM|ər|ən}}<br />''Comirnaty'': {{IPAc-en|k|oʊ|ˈ|m|ɜːr|n|ə|t|i}} {{respell|koh|MUR|nə|tee}}<ref name="fiercepharma"/>
| tradename = Comirnaty<ref name="Swiss authorization" /><ref name="Comirnaty EPAR" /><ref name="Comirnaty global" />
| Drugs.com = {{drugs.com|mtm|pfizer-biontech-covid-19-vaccine}}
| MedlinePlus = a621003
| licence_EU = yes
| DailyMedID = Pfizer–BioNTech_COVID-19_Vaccine
| licence_US = <!-- FDA may use generic or brand name (generic name preferred) -->
| pregnancy_AU = B1
| pregnancy_AU_comment = <ref>{{cite web|title=Comirnaty|url=https://www.tga.gov.au/apm-summary/comirnaty|access-date=25 January 2021|website=[[Therapeutic Goods Administration]] (TGA)|archive-date=1 February 2021|archive-url=https://web.archive.org/web/20210201143845/https://www.tga.gov.au/apm-summary/comirnaty|url-status=live}}</ref>
| pregnancy_category =
| routes_of_administration = [[Intramuscular injection|Intramuscular]]
| ATC_prefix = None <!-- scheduled to be J07BX03 in 2022 -->
| ATC_suffix =
| ATC_supplemental =
<!-- Legal status -->
| legal_AU = S4
| legal_AU_comment = <ref>{{cite web | title=Comirnaty (BNT162b2 [mRNA]) COVID-19 Vaccine Product Information | website=[[Therapeutic Goods Administration]] (TGA) | url=https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-PI-01092-1 | format=PDF | access-date=25 January 2021 | archive-date=2 February 2021 | archive-url=https://web.archive.org/web/20210202073852/https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-PI-01092-1 | url-status=live }}</ref><ref>{{cite report | url=https://www.tga.gov.au/sites/default/files/auspar-bnt162b2-mrna-210125.pdf | title=Australian Public Assessment Report for BNT162b2 (mRNA) | publisher=[[Therapeutic Goods Administration]] (TGA) | access-date=25 January 2021 | date= | archive-date=26 January 2021 | archive-url=https://web.archive.org/web/20210126144716/https://www.tga.gov.au/sites/default/files/auspar-bnt162b2-mrna-210125.pdf | url-status=live }}</ref>
| legal_BR = Approved
| legal_BR_comment = <ref>{{cite web|url=https://g1.globo.com/bemestar/vacina/noticia/2021/02/23/anvisa-concede-registro-definitivo-a-vacina-da-pfizer.ghtml|title=Vacina da Pfizer é a 1ª contra a Covid a obter registro definitivo no Brasil|date=23 February 2021|access-date=20 March 2021|website=G1|language=pt-br|archive-date=17 March 2021|archive-url=https://web.archive.org/web/20210317140631/https://g1.globo.com/bemestar/vacina/noticia/2021/02/23/anvisa-concede-registro-definitivo-a-vacina-da-pfizer.ghtml|url-status=live}}</ref>
| legal_CA = Schedule D; Authorized by interim order
| legal_CA_comment = <ref name="hcreg">{{cite web |title=Regulatory Decision Summary – Pfizer–BioNTech COVID-19 Vaccine |url=https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detailTwo.html?linkID=RDS00730 |publisher=[[Health Canada]] |date=9 December 2020 |archive-date=9 December 2020|archive-url=https://web.archive.org/web/20201209160459/https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detailTwo.html?linkID=RDS00730|url-status=live}}</ref><ref name="CA Pfizer-BioNTech product description" /><ref name="CA Regulatory Decision Summary" />
| legal_DE = <!-- Anlage I, II, III or Unscheduled -->
| legal_DE_comment =
| legal_NZ = <!-- Class A, B, C -->
| legal_NZ_comment =
| legal_UK = Conditional and temporary authorization to supply
| legal_UK_comment = <ref name="MHRA product information" /><ref>{{cite web | title=Conditions of Authorisation for Pfizer/BioNTech COVID-19 vaccine | website=[[Medicines and Healthcare products Regulatory Agency]] (MHRA) | date=31 December 2020 | url=https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/conditions-of-authorisation-for-pfizerbiontech-covid-19-vaccine | access-date=8 January 2021 | archive-date=26 February 2021 | archive-url=https://web.archive.org/web/20210226081445/https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/conditions-of-authorisation-for-pfizerbiontech-covid-19-vaccine | url-status=live }}</ref>
| legal_US = Standing Order; Unapproved
| legal_US_comment = ([[Emergency Use Authorization]])<ref name="FDA PR 20201211">{{cite press release | title=FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine | publisher=U.S. [[Food and Drug Administration]] (FDA) | date=11 December 2020 | url=https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19 | access-date=11 December 2020 | archive-date=18 March 2021 | archive-url=https://web.archive.org/web/20210318070621/https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19 | url-status=live }} {{PD-notice}}</ref><ref name="Pfizer-BioNTech COVID-19 Vaccine FDA label">{{cite web | title=Pfizer-Biontech COVID-19 Vaccine- bnt162b2 injection, suspension | website=DailyMed | url=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=908ecbe7-2f1b-42dd-94bf-f917ec3c5af8 | access-date=14 December 2020 | archive-date=29 January 2021 | archive-url=https://web.archive.org/web/20210129052412/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=908ecbe7-2f1b-42dd-94bf-f917ec3c5af8 | url-status=live }}</ref><ref name="FDAEUA">{{cite report | url=https://www.fda.gov/media/144416/download | format=PDF | title=Pfizer–BioNTech COVID-19 Vaccine Emergency Use Authorization Review Memorandum | website=U.S. [[Food and Drug Administration]] (FDA) | date=14 December 2020 | access-date=14 December 2020 | archive-date=29 January 2021 | archive-url=https://web.archive.org/web/20210129152900/https://www.fda.gov/media/144416/download | url-status=live }} {{PD-notice}}</ref><ref name="CDC standing order">{{cite web | url=https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/downloads/standing-orders.pdf | title=Pfizer–BioNTech COVID-19 Vaccine Standing Orders for Administering Vaccine to Persons 12 Years of Age and Older | publisher=[[Centers for Disease Control and Prevention]] (CDC) | access-date=5 March 2021 | archive-date=2 March 2021 | archive-url=https://web.archive.org/web/20210302001413/https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/downloads/standing-orders.pdf | url-status=live }}</ref>
| legal_EU = Conditional marketing authorization granted
| legal_EU_comment = <ref name="Comirnaty EPAR" />
| legal_UN = <!-- N I, II, III, IV / P I, II, III, IV -->
| legal_UN_comment =
| legal_status = <!-- For countries not listed above --> {{abbr|CH|Switzerland|class=country-name}}: Rx-only{{explain|date=January 2021}}<ref name="Swiss authorization" />
{{abbr|ZA|South Africa|class=country-name}}: Section 21 <ref name="businesstech.co.za">{{cite web|title=South Africa approves Pfizer Covid-19 vaccine for emergency use|url=https://businesstech.co.za/news/trending/476360/south-africa-approves-pfizer-covid-19-vaccine-for-emergency-use/|access-date=18 March 2021|archive-date=18 March 2021|archive-url=https://web.archive.org/web/20210318184922/https://businesstech.co.za/news/trending/476360/south-africa-approves-pfizer-covid-19-vaccine-for-emergency-use/|url-status=live}}</ref><ref>{{cite web| vauthors = Nkanjeni U |title=Pfizer-BioNTec approved for emergency use in SA: here is what you need to know about the vaccine|url=https://www.timeslive.co.za/news/south-africa/2021-03-18-pfizer-biontec-approved-for-emergency-use-in-sa-here-is-what-you-need-to-know-about-the-vaccine/|access-date=19 March 2021|website=TimesLIVE|archive-date=19 April 2021|archive-url=https://web.archive.org/web/20210419054615/https://www.timeslive.co.za/news/south-africa/2021-03-18-pfizer-biontec-approved-for-emergency-use-in-sa-here-is-what-you-need-to-know-about-the-vaccine/|url-status=live}}</ref>
Others: [[List of COVID-19 vaccine authorizations#Pfizer-BioNTech|List of Pfizer-BioNTech COVID-19 vaccine authorizations]]
<!-- Identifiers -->
| CAS_number = 2417899-77-3
| CAS_supplemental =
| PubChem =
| PubChemSubstance = 434370509
| IUPHAR_ligand =
| DrugBank = DB15696
| ChemSpiderID =
| UNII = 5085ZFP6SJ
| KEGG = D11971
| ChEBI =
| ChEMBL =
| NIAID_ChemDB =
| synonyms = BNT162b2, COVID-19 mRNA vaccine (nucleoside-modified)
<!-- Chemical and physical data -->
}}
| |||